![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/8e33f9d1-8d6e-4d59-93c0-3a3d193f7cd0/gr2_lrg.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![8 Noticeable Symptoms of Omicron Sub-variants of Covid-19 - Vejthani Hospital | JCI Accredited International Hospital in Bangkok, Thailand. 8 Noticeable Symptoms of Omicron Sub-variants of Covid-19 - Vejthani Hospital | JCI Accredited International Hospital in Bangkok, Thailand.](https://www.vejthani.com/wp-content/uploads/2022/07/64295F98D3CC43D71EEF838561ABAE8D4297987F-1-1024x1024.png)
8 Noticeable Symptoms of Omicron Sub-variants of Covid-19 - Vejthani Hospital | JCI Accredited International Hospital in Bangkok, Thailand.
![SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7109e1_TransmissionWithinHouseholds_IMAGE_25Feb22_1200x675.jpg?_=65736)
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR
![What You Need to Know About XBB.1.5, the Latest Omicron Variant | Johns Hopkins | Bloomberg School of Public Health What You Need to Know About XBB.1.5, the Latest Omicron Variant | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/social_image/public/2023-01/xbb15-g1336071300.jpg?itok=-KJH--Tb)
What You Need to Know About XBB.1.5, the Latest Omicron Variant | Johns Hopkins | Bloomberg School of Public Health
![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/7eb37bf9-6d97-485f-805e-207b29973336/gr1_lrg.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![Omicron symptoms: Here's what to expect — and what we know about the severity : Shots - Health News : NPR Omicron symptoms: Here's what to expect — and what we know about the severity : Shots - Health News : NPR](https://media.npr.org/assets/img/2022/01/05/gettyimages-1236904617-50_custom-8ee1fa3d5eb9c3b0c394571a88c2426fceb27bc5-s1100-c50.jpg)
Omicron symptoms: Here's what to expect — and what we know about the severity : Shots - Health News : NPR
![Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/f33bfa31-7fc7-4f45-9975-224949e2f730/gr1_lrg.jpg)